{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-009749","form_type":"8-K","ticker":"HTCR","cik":"0001892322","company_name":"HeartCore Enterprises, Inc.","filed_at":"2023-03-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.387265+00:00","generated_at":"2026-06-17T09:49:16.339478+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"HeartCore Q4 revenue $2.0M, net loss $1.4M; full year net loss $6.7M","bullets":["Q4 2022 revenue $2.0M (down from $2.4M YoY); net loss $1.4M ($0.08/diluted share) vs loss $742k ($0.05) YoY.","Full year 2022 revenue $8.8M (down from $10.8M); net loss $6.7M ($0.37/diluted share) vs loss $327k ($0.02) YoY.","Cash and equivalents $7.2M at Dec 31, 2022, up from $3.1M at Dec 31, 2021.","Operational highlights: 903 enterprise customers; acquired 51% of Sigmaways; signed 9 Go IPO clients.","CEO expects 2023 to be an inflection point; Go IPO client SBC Medical valued at $1.2B, warrants valued ~$32.4M."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-009749","json":"https://secwatch.observer/filing/0001493152-23-009749.json","markdown":"https://secwatch.observer/filing/0001493152-23-009749.md","text":"https://secwatch.observer/filing/0001493152-23-009749.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1892322/000149315223009749/0001493152-23-009749-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1892322/000149315223009749/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T09:49:16.339478+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"39670aaa143152d3befd292a6901bdc1af52b65c","claim":"HeartCore Enterprises, Inc. reported fourth quarter ended December 31, 2022 results: revenue $2.0 million, net income $1.4 million, or $0.08 per diluted share (net loss), EPS $0.08 per diluted share (net loss).","evidence_excerpt":"full year as a publicly traded company on the Nasdaq on a high note and expect 2023 to be an inflection point for HeartCore.” Fourth Quarter 2022 Financial Results Revenues were $2.0 million compared to $2.4 million in the same period last year. The decrease in revenues was due to lower sales of on-premise software and the effects of turbulence within the broader","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1892322/000149315223009749/0001493152-23-009749-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter ended December 31, 2022"},{"label":"Revenue","value":"$2.0 million"},{"label":"Net income","value":"$1.4 million, or $0.08 per diluted share (net loss)"},{"label":"EPS","value":"$0.08 per diluted share (net loss)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"525783f909b2d2bfab66cf1e506ee3c9a3faa8d0","claim":"HeartCore Enterprises, Inc. reported full year ended December 31, 2022 results: revenue $8.8 million, net income $6.7 million (net loss), EPS $0.37 per diluted share (net loss).","evidence_excerpt":"share last year. The increase in net loss was primarily due to an increase in operating expenses and a decrease in revenues. Full Year 2022 Financial Results Revenues were $8.8 million compared to $10.8 million last year. The decrease in revenues was primarily due to a large, five-year CXM contract being renewed in 2021 and the ongoing depreciation of the","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1892322/000149315223009749/0001493152-23-009749-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year ended December 31, 2022"},{"label":"Revenue","value":"$8.8 million"},{"label":"Net income","value":"$6.7 million (net loss)"},{"label":"EPS","value":"$0.37 per diluted share (net loss)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}